Skip to content

Clinical trials

Phase 1 Small Cell Lung Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1 Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20151
20161
20185
20191
20202
20221
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
AstraZeneca3
Eli Lilly and Company2
Hoffmann-La Roche2
Amgen1
GlaxoSmithKline1
Millennium Pharmaceuticals, Inc.1
NiKang Therapeutics, Inc.1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma18
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Ovarian Neoplasms4
Neoplasm Metastasis3
Stomach Neoplasms3
Triple Negative Breast Neoplasms3
Breast Neoplasms2
Endometrial Neoplasms2
Esophageal Squamous Cell Carcinoma2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.